+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

CSF monoamine metabolism in patients with tardive dyskinesia: effect of oxypertine and hydroxyzine pamoate



CSF monoamine metabolism in patients with tardive dyskinesia: effect of oxypertine and hydroxyzine pamoate



Folia Psychiatrica et Neurologica Japonica 37(2): 129-135



Cerebrospinal fluid (CSF) HVA, MHPG, 5-HIAA, cAMP and cGMP concentrations were measured in schizophrenic patients with tardive dyskinesia before and after a three-week administration of oxypertine (n = 4), hydroxyzine pamoate (n = 4) or placebo (n = 4). The oxypertine administration resulted in a reduction of the CSF HVA concentration and an elevation of the MHPG and cAMP concentrations, associated with a clinical improvement in tardive dyskinesia. The hydroxyzine administration reduced the CSF 5-HIAA concentration in all the patients and the CSF HVA concentration in two of four patients with a clinical improvement. A reduction in the CSF HVA concentration associated with possible therapeutic effects of oxypertine or hydroxyzine may suggest the normalization of a hyperdopaminergic state. Discussions were held that functional disorders of not only the dopaminergic system but the norepinephrinergic and serotoninergic systems may relate to the pathogenesis of tardive dyskinesia.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 042429321

Download citation: RISBibTeXText

PMID: 6200411

DOI: 10.1111/j.1440-1819.1983.tb00312.x


Related references

Tardive dyskinesia and neurotransmitters: effects of sodium valproate, cyproheptadine, oxypertine, hydroxyzine pamoate and Ca-hopantenate on monoamine metabolites, cyclic nucleotides and gamma-aminobutyric acid in human cerebrospinal fluid. Clinical Therapeutics 7 Spec No: 1-17, 1984

Tardive dyskinesia and neurotransmitters effects of sodium valproate cyproheptadine oxypertine hydroxyzine pamoate and calcium hopantenate on monoamine metabolites cyclic nucleotides and gamma aminobutyric acid in human cerebrospinal fluid. Clinical Therapeutics 7(SPEC ISSUE): 1-17, 1984

Cerebro spinal fluid mono amine metabolism in patients with tardive dys kinesia effect of oxypertine and hydroxyzine pamoate. Folia Psychiatrica et Neurologica Japonica 37(2): 129-136, 1983

Amine metabolism in patients with tardive dys kinesia effects of oxypertine and hydroxyzine pamoate. Okayama Igakkai Zasshi 92(5-6): 567-574, 1980

Oxypertine for Tardive Dyskinesia. British Journal of Psychiatry 136(5): 522-523, 1980

Oxypertine for tardive dyskinesia. British Journal of Psychiatry 136: 522-523, 1980

Oxypertine in tardive dyskinesia. Irish Medical Journal 78(7): 202-203, 1985

A controlled trial of oxypertine in tardive dyskinesia. International Pharmacopsychiatry 15(5): 281-291, 1980

Oxypertine in Tardive Dyskinesia: An 8-week Controlled Study. British Journal of Psychiatry 144(1): 48-52, 1984

Oxypertine in tardive dyskinesia: an 8-week controlled study. British Journal of Psychiatry 144: 48-52, 1984

Conscious sedation of pediatric dental patients: an investigation of chloral hydrate, hydroxyzine pamoate, and meperidine vs. chloral hydrate and hydroxyzine pamoate. Pediatric Dentistry 13(1): 10-19, 1991

Oxypertine in tardive dyskinesia: a long-term controlled study. Acta Psychiatrica Scandinavica 74(5): 446-450, 1986

Hydroxyzine-associated tardive dyskinesia. Annals of Neurology 11(4): 435, 1982

Prevalence of tardive dyskinesia, tardive dystonia, and respiratory dyskinesia among Chinese psychiatric patients in Hong Kong. American Journal of Psychiatry 149(8): 1081-1085, 1992

An animal model for coexisting tardive dyskinesia and tardive parkinsonism: a glutamate hypothesis for tardive dyskinesia. Clinical Neuropharmacology 16(1): 90-95, 1993